{"id":"NCT01272934","sponsor":"Novartis","briefTitle":"Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain","officialTitle":"A Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-01","primaryCompletion":"2011-08","completion":"2011-08","firstPosted":"2011-01-10","resultsPosted":"2013-01-15","lastUpdate":"2013-01-24"},"enrollment":205,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Ankle Sprain"],"interventions":[{"type":"DRUG","name":"Diclofenac Sodium","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Diclofenac sodium topical gel 1%","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy of DSG 1% compared with placebo applied four times a day in subjects with acute ankle sprains under 'in-use' conditions, in particular with regard to pain relief.","primaryOutcome":{"measure":"Pain on Movement","timeFrame":"72 hours","effectByArm":[{"arm":"Diclofenac Sodium Topical Gel 1%","deltaMin":25.6,"sd":15.9},{"arm":"Placebo","deltaMin":61.2,"sd":16.6}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":6,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":102},"commonTop":["Infections and infestations","Gastrointestinal disorders","Hepatobiliary disorders","Nervous system disorders","Skin and subcutaneous tissue disorders"]}}